Cancer Vaccines Market Forecast Highlights Expansion From $10.65 Billion To $18.2 Billion Through 2030
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Cancer Vaccines Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The market for cancer vaccines has experienced significant expansion in recent years. Projections indicate that it will rise from $9.36 billion in 2025 to $10.66 billion in 2026, reflecting a compound annual growth rate (CAGR) of 13.9%. This historical growth is largely explained by several factors: a rising incidence of cancer worldwide, the constrained efficacy of traditional therapeutic approaches, heightened public understanding of immunotherapy as a treatment option, increased funding directed toward oncology investigations, and early-stage regulatory endorsements granted for cancer vaccines.
The cancer vaccines market is projected to experience significant expansion over the coming years, reaching an estimated value of $18.2 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.3%. This anticipated growth during the forecast period is fueled by progress in vaccine platforms and delivery mechanisms, a growing uptake of customized cancer vaccines, an expanding array of clinical trials for therapeutic vaccines, heightened governmental investment in cancer research, and an increased need for combination cancer therapies. Key developments shaping this period include the accelerated creation of therapeutic cancer vaccines, a heightened emphasis on personalized and targeted immunotherapies, an uptick in clinical investigations into novel vaccine technologies, the broadening of preventive vaccination initiatives for cancer, and strengthened partnerships between pharmaceutical firms and research institutions.
Download A Free Sample Report For Comprehensive Market Insights:
Cancer Vaccines Market Expansion Drivers: What Is Shaping Future Growth?
An anticipated rise in governmental investment in research and development is expected to fuel the expansion of the cancer vaccines market moving forward. Government funding refers to financial resources allocated by a government to support specific objectives. This funding for research and development is increasing to foster innovation and speed up the creation of new technologies and treatments aimed at addressing pressing health and economic issues. Cancer vaccines contribute to this government investment by generating avenues for backing preventive and therapeutic innovations, thereby encouraging greater financial support for vaccine research initiatives. For example, in September 2023, the National Cancer Institute, a government agency based in the United States, received a budget of $7.3 billion from the United States Congress for the fiscal year 2023, marking an increase of $408 million compared to 2022. Consequently, the growing government funding for research and development is propelling the advancement of the cancer vaccines market.
Cancer Vaccines Market Segmentation: How Is The Market Structured Across Key Categories?
The cancer vaccines market covered in this report is segmented –
1) By Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
2) By Technology: Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines
3) By Cancer Type: Prostate, Cervical, Colorectal, Throat, Other Cancer Types
4) By End-User: Cancer Treatment Centers, Research Institutes
Subsegments:
1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines
2) By Therapeutic Cancer Vaccines: Sipuleucel-T (Provenge), Talimogene Laherparepvec (T-VEC), Other Therapeutic Vaccines
Cancer Vaccines Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Key players in the cancer vaccines market are placing a stronger emphasis on developing quadrivalent vaccines as a strategy to boost their market revenues. Quadrivalent vaccines are designed to provide protection against four distinct strains or variants of a given virus or bacteria. A notable example occurred in January 2023, when the Serum Institute of India, a biotechnology firm based in India, introduced CERVAVAC, the country’s first domestically produced cervical cancer vaccine. This vaccine targets HPV types 16 and 18, along with types 6 and 11—strains that account for a minimum of 70% of cervical cancer cases. Its administration schedule includes two doses for individuals aged 9 to 14, and three doses for those between 15 and 26 years old.
Cancer Vaccines Market Competitive Landscape And Leading Companies
Major companies operating in the cancer vaccines market are GlaxoSmithKline plc, Merck & Co. Inc., Aduro Biotech Inc., AstraZeneca PLC, Dendreon Corporation, Astellas Pharma Inc., Sanofi SA, Sanpower Group, CSL Limited, Pfizer Inc., Serum Institute of India Pvt. Ltd., Advantagene Inc., Advaxis Inc., Agenus Inc., Altor BioScience Corporation, Argos Therapeutics Inc., Oncothyreon Inc., Oncovir Inc., Oxford BioMedica plc., Prima BioMed Ltd., Sotio LLC, Transgene SA, Ubivac LLC, Vaccinogen and Vaxon Biotech, Bavarian Nordic A/S, Bharat Biotech International Limited, Bristol-Myers Squibb Company, Dynavax Technologies Corporation, Emergent BioSolutions Inc., Galena Biopharma Inc., Moderna Inc., Biothera Pharmaceuticals Inc., Celldex Therapeutics Inc., Genexine Inc., Gritstone Oncology Inc., Heat Biologics Inc., ISA Pharmaceuticals B.V., Northwest Biotherapeutics Inc., OncBioMune Pharmaceuticals Inc., TapImmune Inc., Vaxil Bio Ltd., VBI Vaccines Inc., Ziopharm Oncology Inc.
Access The Complete Cancer Vaccines Market Report:
Cancer Vaccines Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the cancer vaccines market in 2025. The regions covered in the cancer vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
